MGLMX | TARZX | MGLMX / TARZX | |
Total Expense Ratio | 0.94 | 1.05 | 90% |
Annual Report Gross Expense Ratio | 0.95 | 1.10 | 86% |
Fund Existence | 11 years | 7 years | - |
Gain YTD | 3.611 | 7.739 | 47% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 25000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.22B | 350M | 633% |
Annual Yield % from dividends | 2.51 | 0.82 | 307% |
Returns for 1 year | 2.42 | 11.27 | 21% |
Returns for 3 years | -3.45 | 15.20 | -23% |
Returns for 5 years | 15.05 | 30.48 | 49% |
Returns for 10 years | 23.15 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VIGRX | 233.81 | 1.03 | +0.44% |
Vanguard Growth Index Investor | |||
GSVRX | 15.87 | 0.06 | +0.38% |
Goldman Sachs Large Cap Value R | |||
JAGLX | 66.79 | 0.24 | +0.36% |
Janus Henderson Global Life Sciences T | |||
GPRIX | 16.74 | N/A | N/A |
Grandeur Peak Global Reach Instl | |||
FIQFX | 46.85 | -0.02 | -0.04% |
Fidelity Advisor China Region Z |